Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-17 to 2024-01-18
Current total value of award: $6.27
Description: 4563342929!INSULIN HUMAN INJECTION MODIFIED 100 USP